The Controversy Surrounding Ozempic: A Closer Look at the Weight Loss Drug
Title: The Controversy Surrounding Ozempic: A Weight Loss Solution or Potential Health Risk?
If you’ve been searching for weight loss solutions online, you’ve likely come across the buzz surrounding the Type 2 diabetes drug Ozempic. This once-weekly injection, containing the active drug semeglutide, has gained popularity for its potential to aid in weight loss. However, the drug’s use for weight loss purposes has sparked controversy among doctors and experts.
Although Ozempic was approved by the US FDA in 2017 for treating diabetes, its weight loss side effects were discovered about ten years ago. Hollywood celebrities like Oprah Winfrey, Melissa McCarthy, and Sharon Osbourne have openly admitted to using the drug for shedding pounds. Despite not being approved locally by the Chemistry Food and Drug Division, access to Ozempic is not difficult, with individuals willing to pay around $4,000 to $5,000 for a month’s supply.
Dr. Andrew Dhanoo, president of the Diabetic Association of Trinidad and Tobago, acknowledges the potential benefits of drugs like Ozempic for weight management but warns of potential side effects. He cautions against using the medication solely for weight loss, emphasizing the importance of addressing underlying issues such as unhealthy relationships with food and physical inactivity.
While Ozempic is not considered addictive, its high cost and limited supply have led to illicit practices like the “suitcase trade,” where individuals purchase medications abroad and sell them at a profit locally. Dr. Dhanoo urges caution against buying medications from illegitimate sources and stresses the need for proper distribution channels to ensure access for those who truly need it.
In conclusion, while Ozempic may offer benefits for weight management, it should be used under the close supervision of a specialist. Addressing the root causes of obesity and maintaining a healthy lifestyle are crucial for long-term success in weight management.
